Prevention of early liver injury by breviscapine in streptozotocin-induced diabetic rats

Planta Medica

Volumn 73, Issue 5, 2007, Pages 433-438

  Wu, Yong Gui ^a   Xia, Ling Ling ^a   Lin, Hui ^a   Zhou, Dian ^a   Qian, Hao ^a   Lin, Shan Tan ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Breviscapine; Diabetes; Liver; Macrophage; Oxidative stress; Transforming growth factor 1

Indexed keywords

BREVISCAPINE; CATALASE; ERIGERON BREVISCAPUS EXTRACT; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG STRUCTURE; FATTY LIVER; IMMUNOHISTOCHEMISTRY; LIPID LIVER LEVEL; LIPID PEROXIDATION; LIVER FIBROSIS; LIVER INJURY; LIVER WEIGHT; MACROPHAGE; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; DRUGS, CHINESE HERBAL; ERIGERON; FLAVONOIDS; LIPID METABOLISM; LIPID PEROXIDATION; LIVER DISEASES; MALE; MALONDIALDEHYDE; PLANTS, MEDICINAL; RATS; RATS, SPRAGUE-DAWLEY;

ERIGERON BREVISCAPUS; RATTUS;

EID: 34250303950     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-967182     Document Type: Article

References (28)

1. Stone BG, Van Thiel DH. Diabetes mellitus and the liver. Semin Liver Dis 1985; 1: 8-28.
2. Keefe E, Adesman P, Stenze P. Steatosis and cirrhosis in an obese diabetic. Dig Dis Sci 1987; 32: 441-5.
3. West IC. Radicals and oxidative stress in diabetes. Diabet Med 2000; 17: 171-80.
4. Baydas G, Canatan H, Turkoglu A. Comparative analysis of the protective effects of melatonin and vitamin E on streptozotocin-induced diabetes mellitus. J Pineal Res 2002; 32: 225-30.
5. de Cavanagh EMV, Inserra F, Toblli J, Stella I, Fraga CG, Ferder L. Enalapril attenuates oxidative stress in diabetic rats. Hypertension 2001; 38: 130-36.
6. Zhang RW, Zhang YL, Wang JS, Lin YY, Shang B. Isolation and identification of flavoroids from shortscape fleabane (Erigeron breviscapus). Chin Trad Herb Drugs 1988; 19: 99-201 [in Chinese].
7. Chen X X, He B, Chen YY. Mechanisms of inhibitory effects of breviscapine on lipid peroxidation in rat brain mitochondria. J Chin Pharm Sci 1998; 7: 209-13 [in Chinese].
8. Ali A, Gan L, Liu Q, Liu H, Xu HB. Antioxidant effect of scutellarin and its antagonistic action on the liver toxicity of Se in rats. Chin Pharmacol Bull 2003; 19: 113-5 [in Chinese].
9. Shuai J, Dong WW. Experimental research of PKC inhibitor, erigeron breviscapus on the ischemic/reperfusion brain injury. Chin Pharmacol Bull 1998; 14: 75-7 [in Chinese].
10. He W, Liu YM, Chen H, Zeng FD. Effect of breviscapine on brain edema and neutrophil infiltration induced by focal cerebral ischemia and reperfusion in rats. Chin J Pharmacol Toxicol 2004; 18: 161-5 [in Chinese].
11. Zhang Z, Sun M, Wang H, Le J. Protective effect of erigeron injections on hepatotoxicity induced by intestinal ischemia-reperfusion in mice. J Hyg Res 2001; 30: 1-3 [in Chinese].
12. Yang XF, He W, Lu WH, Zeng FD. Effects of scutellarin on liver function after brain ischemia/reperfusion in rats. Acta Pharmacol Sin 2003; 24: 1118-24.
13. Folch J, Lees M, Slone Stanley GH. A simple method for the isolaton and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497-509.
14. Foster LB, Dunn RT. Stable reagents for determination of serum triglycerides by a colorimetric Hantzsch condensation method. Clin Chem 1973; 19: 338-40.
15. Parekh AC, Jung RT. Cholesterol determination with ferric acetateuranyl acetate and sulphuric acid-ferrous sulphate reagents. Anal Chem 1970; 42: 1423-7.
16. Morrison WR, Smith LM. Preparations of fatty acid methyl esters and dimethyl acetals from lipids with boron fluoride methanol. J Lipid Res 1964; 5: 600-7.
17. Toblli JE, Ferder L, Stella I, Angerosa M, Inserra F. Enalapril prevents fatty liver in nephritic rats. J Nephrol 2002; 15: 358-67.
18. Bradford MM. A rapid and sensitive method of the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976; 72: 248-54.
19. Busaranogla M, Acbay O, Sonsuz A. A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis. J Hepatol 1999; 31: 384.
20. Liu H, Yang XL, Wang Y, Tang XQ, Jiang DY, Xu HB. Protective effects of scutellarin on superoxide-induced oxidative stress in rat cortical synaptosomes. Acta Pharmacol Sin 2003; 24: 1113-7.
21. Hensley K, Kobinson KA, Gabbita SP, Salsman S, Floyd RA. Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med 2002; 28: 1456-62.
22. Poli G, Parola M. Oxidative damage and fibrogenesis. Free Radic Biol Med 1997; 22: 287-305.
23. Dooley S, Delvoux B, Lahme B, Mangasser-Stephan K, Gressner AM. Modulation of transforming growth factor β response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology 2000; 31: 1094-106.
24. Bedossa P, Paradis V. Transforming growth factor-beta (TGF-beta): a key-role in liver fibrogenesis. J Hepatol 1995; 22: 37-42.
25. Olaso E, Friedman SL. Molecular regulation of hepatic fibrogenesis. J Hepatol 1998; 29: 836-47.
26. Bissell DM, Roulot D, George J. Transforming growth factor β and the liver. Hepatology 2001; 34: 859-67.
27. Starkel P, Sempoux C, Leclercq I, Herin M, Deby C, Desager JP et al. Oxidative stress, KLF6 and transforming growth factor-β up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. J Hepatol 2003; 39: 538-46.
28. Parola M, Muraca R, Dianzani I, Barrera G, Leonarduzzi G, Bendinelli P et al. Vitamin E dietary supplementation inhibits transforming growth factor β1 gene expression in the rat liver. FEBS Lett 1992; 308: 267-70.